| Tap a line for its trend | Last 12Mto Sep 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 79.98× | 79.98× | 69.72× | 58.42× | 53.05× | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 2.25× | 2.42× | 2.15× | 1.86× | 2.59× | ||
| 1.20× | 1.20× | 1.11× | 1.12× | 1.22× | ||
| 1.24× | 1.24× | 1.21× | 1.03× | 1.01× | ||
| 0.83× | 0.83× | 0.81× | 0.68× | 0.68× |
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
Ratios — % unless marked × 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Last 12M 30/09/2026 | |
|---|---|---|---|---|---|---|
| Receivable Days (DSO) | 53.05 | 58.42 | 69.72 | 79.98 | 79.98 | |
| Working Capital Turnover | 2.59 | 1.86 | 2.15 | 2.42 | 2.25 | |
| Asset Turnover | 1.22 | 1.12 | 1.11 | 1.20 | 1.20 | |
| Cash Conversion (CFO/Net Income) | 1.01 | 1.03 | 1.21 | 1.24 | 1.24 | |
| CFO/EBITDA | 0.68 | 0.68 | 0.81 | 0.83 | 0.83 |